Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2020;71(3):209–49.

Google Scholar 

‌2. Endometrial cancer statistics | World Cancer Research Fund International [Internet]. WCRF International. Available from: https://www.wcrf.org/cancer-trends/endometrial-cancer-statistics/

Koppikar S, Oaknin A, GovindBabu K, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open. 2023;8(1):100774–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cancer Today [Internet]. gco.iarc.who.int. Available from: https://gco.iarc.fr/today/fact-sheets-populations(2020)

Morrison J, Balega J, Buckley L, et al. British gynaecological cancer society (BGCS) uterine cancer guidelines: recommendations for practice. Eur J Obstet Gynecol Reprod Biol. 2021;270(50):89.

Google Scholar 

Alexa M, Hasenburg A, Battista MJ. The TCGA molecular classification of endometrial cancer and its possible impact on adjuvant treatment decisions. cancers [Internet]. 2021 Mar 23 [cited 2022 Sep 18];13(6):1478. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005218/#B35-cancers-13-01478

Johnson AL, Medina HN, Schlumbrecht MP, et al. The role of histology on endometrial cancer survival disparities in diverse Florida glubb D, editor. PLoS ONE. 2020;15(7):e0236402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

León‐Castillo A, Gilvazquez E, Nout R, et al. Clinicopathological and molecular characterisation of “multiple‐classifier” endometrial carcinomas. The Journal of Pathology [Internet]. 2020 Mar 1;250(3):312–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065184/

Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecologic Cancer [Internet]. 2021 Jan 1;31(1). Available from: https://ijgc.bmj.com/content/31/1/12#article-bottom

Board WC of TE. Female Genital Tumours [Internet]. publications.iarc.fr. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Female-Genital-Tumours-2020

Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, version 1 2023 nccn clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2023;21(2):181–209.

Article  CAS  Google Scholar 

Cancer Tomorrow [Internet]. gco.iarc.fr. Available from: https://gco.iarc.fr/tomorrow/en

Koskas M, Amant F, Mirza MR, et al. Cancer of the corpus uteri: 2021 update. Int J Gynecol & Obstet. 2021;155(S1):45–60.

Article  Google Scholar 

Rodriguez AC, Blanchard Z, Maurer KA, et al. Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions. Horm Cancer. 2019;10(2–3):51–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benoit L, Pauly L, Phelippeau J, et al. Impact of sociodemographic characteristics on the quality of care in the surgical management of endometrial cancer: an analysis of a national database in the United States. Gynecol Obstet Investig. 2020;85(3):222–8.

Article  Google Scholar 

Soslow RA, Tornos C, Park KJ, et al. Endometrial carcinoma diagnosis: use of figo grading and genomic subcategories in clinical practice: recommendations of the international society of gynecological pathologists. Int J Gynecol Pathol. 2019;8(Suppl 1):S64-74.

Article  Google Scholar 

Berek JS, Matias-Gulu X, Creutzberg C, et al. Endometrial cancer staging subcommittee, FIGO women’s cancer committee. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162:383–94.

Article  Google Scholar 

Vermij L, Smit V, Nout R, et al. Incorporation of molecular characteristics into endometrial cancer management. Histopathology. 2019;76(1):52–63.

Article  PubMed Central  Google Scholar 

León-Castillo A, de Boer SM, Powell ME, et al. Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol. 2020;38(29):3388–97.

Article  PubMed  PubMed Central  Google Scholar 

Przewoźny S, Rogaliński J, de Mezer M, et al. Estrogen receptor (ER) and progesterone receptor (PgR) expression in endometrial cancer—an immunohistochemical assessment. Diagnostics. 2024;14(3):322.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Tran DA, Fu MZ, et al. Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer. J Cancer. 2020;11(7):1693–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buza N. HER2 Testing in endometrial serous carcinoma: time for standardized pathology practice to meet the clinical demand. Arch Pathol Lab Med. 2021;145(6):687–91. https://doi.org/10.5858/arpa.2020-0207-RA. (PMID: 32649220).

Article  CAS  PubMed  Google Scholar 

Fader AN, Roque DM, Siegel E, et al. Randomized phase II trial of carboplatin-paclitaxel compared with carboplatin–paclitaxel–trastuzumab in advanced (Stage III–IV) or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002): updated overall survival analysis. Clin Cancer Res. 2020;26(15):3928–35.

Article  PubMed  PubMed Central  Google Scholar 

Vermij L, Horeweg N, Leon-Castillo A, et al. HER2 status in high-risk endometrial cancers (PORTEC-3): relationship with histotype, molecular classification, and clinical outcomes. Cancers. 2020;13(1):44.

Article  PubMed  PubMed Central  Google Scholar 

Murali R, Davidson B, Fadare O, et al. High-grade endometrial carcinomas. Int J Gynecol Pathol. 2019;38:S40-63.

Article  PubMed  Google Scholar 

Vasilevska D, Semczuk-Sikora A, Lewkowicz D et al .Expression of selected cytokeratins in neoplastic endometrium.The 24th World Congress on Advances in Oncology and 24th International Symposium on Molecular Medicine, Sparta, Greece, 10–12 October 2019. Int J Mol Med. 2019; 44: S47.

Vasilevska D, Rudaitis V, Adamiak-Godlewska A, et al. cytokeratin expression pattern in human endometrial carcinomas and lymph nodes micrometastasis: a mini-review. J Cancer. 2022;13(6):1713–24.

Article  CAS  PubMed  PubMed Central  Google Scholar